Quinoline derivatives as SMO inhibitors

  • US 9,938,292 B2
  • Filed: 03/16/2015
  • Issued: 04/10/2018
  • Est. Priority Date: 03/24/2014
  • Status: Active Grant
First Claim
Patent Images

1. A compound represented by formula (I), or a pharmaceutically acceptable salt thereof,wherein, A is selected from

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×